Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of aberrant glycosylation associated with osteoarthritis based on integrated glycomics methods. | Arthritis Res Ther | 2023 | 37308935 | PubTator, text mining | PubMed |
| A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes. | Cancers (Basel) | 2023 | 37296894 | PubTator, text mining | PubMed |
| Exercise improves subchondral bone microenvironment through regulating bone-cartilage crosstalk. | Front Endocrinol (Lausanne) | 2023 | 37288291 | PubTator, text mining | PubMed |
| Role of Interleukin-36 in inflammatory joint diseases. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 37283111 | PubTator, text mining | PubMed |
| Effects of Immune Cells and Cytokines on Different Cells in OA. | J Inflamm Res | 2023 | 37273484 | PubTator, text mining | PubMed |
| Bioinformatic analysis of biological changes involved in pelvic organ prolapse. | Medicine (Baltimore) | 2023 | 37266648 | PubTator, text mining | PubMed |
| Targeting Some Key Metalloproteinases by Nano-Naringenin and Amphora coffeaeformis as a Novel Strategy for Treatment of Osteoarthritis in Rats. | Pharmaceuticals (Basel) | 2023 | 37259405 | PubTator, text mining | PubMed |
| Epigenetics as a Therapeutic Target in Osteoarthritis. | Pharmaceuticals (Basel) | 2023 | 37259307 | PubTator, text mining | PubMed |
| Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity. | Acta Neuropathol Commun | 2023 | 37259128 | PubTator, text mining | PubMed |
| The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: A potential disease-modifying OA drug. | Osteoarthritis Cartilage | 2023 | 37257556 | PubTator, text mining | PubMed |
| Anti-Inflammatory Effects of Adiponectin Receptor Agonist AdipoRon against Intervertebral Disc Degeneration. | Int J Mol Sci | 2023 | 37239908 | PubTator, text mining | PubMed |
| New Targets and Strategies for Rheumatoid Arthritis: From Signal Transduction to Epigenetic Aspect. | Biomolecules | 2023 | 37238636 | PubTator, text mining | PubMed |
| Chondroprotective Effects of Chondrogenic Differentiated Adipose-Derived Mesenchymal Stem Cells Sheet on Degenerated Articular Cartilage in an Experimental Rabbit Model. | Bioengineering (Basel) | 2023 | 37237645 | PubTator, text mining | PubMed |
| A cytokine-induced spheroid-based in vitro model for studying osteoarthritis pathogenesis. | Front Bioeng Biotechnol | 2023 | 37229489 | PubTator, text mining | PubMed |
| CKLF1 interference alleviates IL‑1β‑induced inflammation, apoptosis and degradation of the extracellular matrix in chondrocytes via CCR5. | Exp Ther Med | 2023 | 37229323 | PubTator, text mining | PubMed |
| CircRNAs in osteoarthritis: research status and prospect. | Front Genet | 2023 | 37229197 | PubTator, text mining | PubMed |
| Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction. | Cardiovasc Res | 2023 | 37216909 | PubTator, text mining | PubMed |
| Oxidized LDL-mediated upregulation of ADAMTS-4 in monocytes/macrophages involves ROS-NF-κB-SIRT-1 pathway. | Physiol Int | 2023 | 37216221 | PubTator, text mining | PubMed |
| Aging, cell senescence, the pathogenesis and targeted therapies of intervertebral disc degeneration. | Front Pharmacol | 2023 | 37214476 | PubTator, text mining | PubMed |
| Injectable biomaterial induces regeneration of the intervertebral disc in a caprine loaded disc culture model. | Biomater Sci | 2023 | 37204288 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=12